Pharming Free Cash Flow Yield from 2010 to 2025

PHAR Stock  USD 8.68  0.14  1.64%   
Pharming Group Free Cash Flow Yield yearly trend continues to be relatively stable with very little volatility. Free Cash Flow Yield is likely to drop to -0.02. Free Cash Flow Yield is a financial solvency ratio that compares the free cash flow per share Pharming Group NV is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share. View All Fundamentals
 
Free Cash Flow Yield  
First Reported
2010-12-31
Previous Quarter
(0.02)
Current Value
(0.02)
Quarterly Volatility
0.20043613
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pharming Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharming Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.2 M, Interest Expense of 6.4 M or Selling And Marketing Expenses of 7.4 M, as well as many indicators such as Price To Sales Ratio of 4.16, Dividend Yield of 0.0 or PTB Ratio of 3.92. Pharming financial statements analysis is a perfect complement when working with Pharming Group Valuation or Volatility modules.
  
Check out the analysis of Pharming Group Correlation against competitors.

Latest Pharming Group's Free Cash Flow Yield Growth Pattern

Below is the plot of the Free Cash Flow Yield of Pharming Group NV over the last few years. It is a financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share. Pharming Group's Free Cash Flow Yield historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharming Group's overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Yield10 Years Trend
Slightly volatile
   Free Cash Flow Yield   
       Timeline  

Pharming Free Cash Flow Yield Regression Statistics

Arithmetic Mean(0.09)
Geometric Mean0.06
Coefficient Of Variation(216.48)
Mean Deviation0.15
Median(0.02)
Standard Deviation0.20
Sample Variance0.04
Range0.6998
R-Value0.61
Mean Square Error0.03
R-Squared0.37
Significance0.01
Slope0.03
Total Sum of Squares0.60

Pharming Free Cash Flow Yield History

2025 -0.019
2024 -0.0181
2023 -0.0201
2022 0.0204
2021 0.0297
2020 0.0686
2019 0.0372

About Pharming Group Financial Statements

Pharming Group shareholders use historical fundamental indicators, such as Free Cash Flow Yield, to determine how well the company is positioned to perform in the future. Although Pharming Group investors may analyze each financial statement separately, they are all interrelated. The changes in Pharming Group's assets and liabilities, for example, are also reflected in the revenues and expenses on on Pharming Group's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Free Cash Flow Yield(0.02)(0.02)

Additional Tools for Pharming Stock Analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.